| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/S0091-6749(97)70013-7 |
| P698 | PubMed publication ID | 9440553 |
| P2093 | author name string | Suda T | |
| Nagata S | |||
| P2860 | cites work | Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family | Q28285445 |
| Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand | Q28513283 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| The Fas death factor | Q29620461 | ||
| Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis | Q30080034 | ||
| Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity | Q33488225 | ||
| Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease | Q34602392 | ||
| Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice | Q36129002 | ||
| Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide | Q36297378 | ||
| Prevention of nephritis in major histocompatibility complex class II-deficient MRL-lpr mice | Q36362973 | ||
| Greatly reduced lymphoproliferation in lpr mice lacking major histocompatibility complex class I. | Q36364361 | ||
| Enhanced and accelerated lymphoproliferation in Fas-null mice | Q37711034 | ||
| The APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice | Q38302171 | ||
| The role of B cell abnormalities in the systemic autoimmune syndromes of lpr and gld mice | Q40745058 | ||
| Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) | Q41371079 | ||
| Reduced development of CD4-8-B220+ T cells but normal autoantibody production in lpr/lpr mice lacking major histocompatibility complex class I molecules | Q41664431 | ||
| Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand | Q41860508 | ||
| The contribution of L3T4+ T cells to lymphoproliferation and autoantibody production in MRL-lpr/lpr mice | Q42019842 | ||
| Cytotoxicity of fresh NK1.1+ T cell receptor alpha/beta+ thymocytes against a CD4+8+ thymocyte population associated with intact Fas antigen expression on the target | Q42942508 | ||
| Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody | Q42942821 | ||
| Fas-mediated cytotoxicity by freshly isolated natural killer cells | Q42942845 | ||
| CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with CD4+T cells | Q45971909 | ||
| Murine lupus in MRL/lpr mice lacking CD4 or CD8 T cells. | Q52206363 | ||
| Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. | Q54177718 | ||
| Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome | Q55670225 | ||
| A role for CD95 ligand in preventing graft rejection | Q59066471 | ||
| Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege | Q63408406 | ||
| Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice | Q68059685 | ||
| Self-nonself discrimination by T cells | Q68090702 | ||
| Activated B cells express functional Fas ligand | Q71012013 | ||
| Expression of Fas in B cells of the mouse germinal center and Fas-dependent killing of activated B cells | Q71363470 | ||
| The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice | Q71678868 | ||
| P433 | issue | 6 Pt 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | S97-101 | |
| P577 | publication date | 1997-12-01 | |
| P1433 | published in | The Journal of Allergy and Clinical Immunology | Q7743550 |
| P1476 | title | Why do defects in the Fas-Fas ligand system cause autoimmunity? | |
| P478 | volume | 100 |
| Q88500089 | Administration of activated lymphocyte-derived DNA accelerates and aggravates lupus nephritis in B6/lpr mice: a new approach to modify a lupus murine model |
| Q35097949 | Aerosol therapy for the treatment of osteosarcoma lung metastases: targeting the Fas/FasL pathway and rationale for the use of gemcitabine |
| Q36659043 | CD8+CD122+CD49dlow regulatory T cells maintain T-cell homeostasis by killing activated T cells via Fas/FasL-mediated cytotoxicity |
| Q62735931 | Caspase 1-independent IL-1β release and inflammation induced by the apoptosis inducer Fas ligand |
| Q74582446 | Combination of molecular mimicry and aberrant autoantigen expression is important for development of anti-Fas ligand autoantibodies in patients with systemic lupus erythematosus |
| Q73862693 | Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients |
| Q39251222 | Dual Role of Fas/FasL-Mediated Signal in Peripheral Immune Tolerance. |
| Q34564667 | Enhanced auto-antibody production and Mott cell formation in FcμR-deficient autoimmune mice. |
| Q28371293 | Estradiol prevents and testosterone promotes Fas-dependent apoptosis in CD4+ Th2 cells by altering Bcl 2 expression |
| Q74610140 | Expression of Fas antigen (CD95) in peripheral blood lymphocytes and in liver-infiltrating, cytotoxic lymphocytes in patients with hepatocellular carcinoma |
| Q27484988 | Fas Ligand Interactions Contribute to CD8+ T-Cell-Mediated Control of West Nile Virus Infection in the Central Nervous System |
| Q28574439 | Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland |
| Q40520855 | Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. |
| Q36572935 | High distribution of CD40 and TRAF2 in Th40 T cell rafts leads to preferential survival of this auto-aggressive population in autoimmunity |
| Q44087976 | Immunoglobulin and autoantibody responses in MRL/lpr mice treated with 'toxic oils'. |
| Q37754703 | Inflammation and arthritis: perspectives of the glycobiologist |
| Q35199945 | Killer B lymphocytes and their fas ligand positive exosomes as inducers of immune tolerance |
| Q38838638 | Liver receptor homolog-1 (NR5a2) regulates CD95/Fas ligand transcription and associated T-cell effector functions. |
| Q99552352 | Longitudinal immune profiling of mild and severe COVID-19 reveals innate and adaptive immune dysfunction and provides an early prediction tool for clinical progression |
| Q73348111 | Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients |
| Q37350948 | Reduced Fas ligand-expressing splenic CD5+ B lymphocytes in severe collagen-induced arthritis. |
| Q23924040 | Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cells |
| Q91993969 | Thalidomide with blockade of co-stimulatory molecules prolongs the survival of alloantigen-primed mice with cardiac allografts |
| Q37393827 | The role of apoptosis in immune hyporesponsiveness following AAV8 liver gene transfer |
Search more.